Sponsored Links

Adding Ipilimumab To Standard Chemotherapy Treatment For Late-Stage Lung Cancer May Improve Survival PDF Print E-mail
Medical News - Lung Cancer
Ipilimumab used in combination with paclitaxel/carboplatin for stage IIIb/IV non-small cell lung cancer showed superior results in progression free survival when compared to paclitaxel/carboplatin alone, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology...

Read more: Lung Cancer News From Medical News Today